Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations would expand definition of “claim for the medicinal ingredient”

Published date27 April 2021
Subject MatterPatents,Generic Drugs,Public Comment,Proposed Amendments,Pharmaceutical Patents,Canada,Comment Period,Food & Drug Regulations,Patented Medicines,PMNOC Regulations,Notice of Compliance,Patent Registration,Abbreviated New Drug Submission (ANDS)
AuthorKatie Lee
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT